Science, Discovery, Tech and Environment · 23 February 2026
UAE unveils two gene therapy projects targeting monogenic autism and paediatric neurodegenerative disorders
Exam-focused facts from the 23 February 2026 current affairs briefing.
Key facts
- Emirates Health Services (EHS) announced two gene therapy initiatives for rare neurological and genetic disorders in children.
- The first project targets monogenic autism and epilepsy, including Beta-Propeller Protein-Associated Neurodegeneration (BPAN).
- Enhanced gene delivery systems will target specific brain cells to improve efficacy and safety.
- The second project will develop genetic interventions, repair faulty genes, and use cell-based therapies for neurodegenerative diseases.
- Artificial intelligence and Emirati Genome Programme data will identify at-risk children for earlier diagnosis.
- Both projects are developed in collaboration with the Children’s Hospital of Philadelphia.